About bio-absorbable stents
The bioabsorbable stents market has evolved with the advances in technology and innovative products in the medical field. Stents are being increasingly used to treat medical conditions. The vendors are focusing on developing products that are safe, easy to use, widely available, and cost-effective. Also, some companies are adopting creative strategies and developing innovative products to ensure product differentiation in the market.
Technavio’s analysts forecast the global bio-absorbable stents market to grow at a CAGR of 40.93% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global bio-absorbable stents market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of bioabsorbable stents.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Bio-Absorbable Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Abbott Laboratories
• Elixir Medical
• Kyoto Medical Planning
• F. Hoffmann-La Roche
Other prominent vendors
• REVA Medical
• Arterial Remodeling Technologies
• Tepha
• Meril Life Sciences
• Amaranth Medical
• Arterius
Market driver
• Increasing prevalence of CADs
• For a full, detailed list, view our report
Market challenge
• Stringent regulation for approval of devices
• For a full, detailed list, view our report
Market trend
• Advent of metallic stents
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: Executive summary
PART 02: Scope of the report
Market overview
Top-vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by material
Polymeric stents
Metallic stents
PART 07: Market segmentation by application
Market overview
PART 08: Market segmentation by end-user
Hospitals
ASCs
PART 09: Geographical segmentation
Bioabsorbable stents market in the Americas
Bioabsorbable stents market in EMEA
Bioabsorbable stents market in APAC
PART 10: Market drivers
Increasing prevalence of CADs
Growing demand for MI procedures
Growing diabetic population
PART 11: Impact of drivers
PART 12: Market challenges
Stringent regulation for approval of devices
Threat of substitute products
Increasing competition among vendors
PART 13: Impact of drivers and challenges
PART 14: Market trends
Advent of metallic stents
Growing popularity of hybrid procedures
Alternative use of vascular stents
PART 15: Vendor landscape
Competitive landscape analysis
PART 16: Key vendor analysis
Boston Scientific
Abbott Laboratories
Elixir Medical
Kyoto Medical Planning
Other prominent vendors
PART 17: Appendix
List of abbreviations
PART 18: Explore Technavio
?
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global bioabsorbable stents market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global bioabsorbable stents market by material 2016
Exhibit 05: Polymeric stents: Market overview
Exhibit 06: Polymeric stents: Products
Exhibit 07: Metallic stents: Market overview
Exhibit 08: Metallic stents: Products
Exhibit 09: Global bioabsorbable stents market by application 2016
Exhibit 10: Global bioabsorbable stents market by end-users 2016
Exhibit 11: Revascularisation procedures in Americas 2006 and 2013 (per 100,000 population)
Exhibit 12: Revascularisation procedures in EMEA 2006 and 2013 (per 100,000 population)
Exhibit 13: Revascularisation procedures in APAC 2006 and 2013 (per 100,000 population)
Exhibit 14: Bioabsorbable stents market: ASCs in Americas
Exhibit 15: Bioabsorbable stents market: ASCs in EMEA
Exhibit 16: Bioabsorbable stents market: ASCs in APAC
Exhibit 17: Americas: Overview of bioabsorbable stents market
Exhibit 18: Bioabsorbable stents market in Americas 2016-2021 ($ billions)
Exhibit 19: Americas: Market metrics in various countries
Exhibit 20: Key takeaway: Bioabsorbable stents market in the US
Exhibit 21: EMEA: Overview of bioabsorbable stents market
Exhibit 22: Bioabsorbable stents market in EMEA 2016-2021 ($ billions)
Exhibit 23: EMEA: Market metrics in various countries
Exhibit 24: Key takeaway: Bioabsorbable stents market in the UK
Exhibit 25: APAC: Overview of bioabsorbable stents market
Exhibit 26: Bioabsorbable stents market in APAC 2016-2021 ($ billions)
Exhibit 27: APAC: Market metrics in various countries
Exhibit 28: Key takeaway: Bioabsorbable stents market in India
Exhibit 29: CHD prevalence by sex and age in US 2015
Exhibit 30: Global prevalence of diabetes 2015 and 2040 (millions)
Exhibit 31: Impact of drivers
Exhibit 32: Bioabsorbable stents under investigation and trials
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Competitive structure analysis of global bioabsorbable stents market 2016
Exhibit 35: Competitive landscape analysis of global bioabsorbable stents market 2016
Exhibit 36: Market penetration of various bioabsorbable stents manufacturers globally 2016
Exhibit 37: Strategic factors determining success for leading companies in global bioabsorbable stents market
Exhibit 38: Boston Scientific: Strength analysis
Exhibit 39: Boston Scientific: Strategy assessment
Exhibit 40: Boston Scientific: Opportunity assessment
Exhibit 41: Abbott Laboratories: Strength assessment
Exhibit 42: Abbott Laboratories: Strategy assessment
Exhibit 43: Abbott Laboratories: Opportunity assessment
Exhibit 44: Elixir Medical: Strength assessment
Exhibit 45: Elixir Medical: Strategy assessment
Exhibit 46: Elixir Medical: Opportunity assessment
Exhibit 47: Kyoto Medical Planning: Strength assessment
Exhibit 48: Kyoto Medical Planning: Strategy assessment
Exhibit 49: Kyoto Medical Planning: Opportunity assessment
Exhibit 50: Other prominent vendors: Bioabsorbable stents market
